Cargando…
Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060365/ https://www.ncbi.nlm.nih.gov/pubmed/25166423 http://dx.doi.org/10.1186/ar4537 |
| _version_ | 1782321359360098304 |
|---|---|
| author | Toussirot, Eric Dumoulin, Gilles |
| author_facet | Toussirot, Eric Dumoulin, Gilles |
| author_sort | Toussirot, Eric |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4060365 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40603652014-06-17 Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply Toussirot, Eric Dumoulin, Gilles Arthritis Res Ther Letter BioMed Central 2014 2014-04-10 /pmc/articles/PMC4060365/ /pubmed/25166423 http://dx.doi.org/10.1186/ar4537 Text en Copyright © 2014 Toussirot and Dumoulin; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Toussirot, Eric Dumoulin, Gilles Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply |
| title | Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply |
| title_full | Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply |
| title_fullStr | Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply |
| title_full_unstemmed | Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply |
| title_short | Response to ‘Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort’– authors’ reply |
| title_sort | response to ‘serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the espoir cohort’– authors’ reply |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060365/ https://www.ncbi.nlm.nih.gov/pubmed/25166423 http://dx.doi.org/10.1186/ar4537 |
| work_keys_str_mv | AT toussiroteric responsetoserumlevelofadiponectinisasurrogateindependentbiomarkerofradiographicdiseaseprogressioninearlyrheumatoidarthritisresultsfromtheespoircohortauthorsreply AT dumoulingilles responsetoserumlevelofadiponectinisasurrogateindependentbiomarkerofradiographicdiseaseprogressioninearlyrheumatoidarthritisresultsfromtheespoircohortauthorsreply |